RecruitingNCT01137825
Blood
Primary cutaneous anaplastic large cell lymphoma
4
studies recruiting now
as of 7 Sept 2026
137
studies registered in total
as of 7 Sept 2026
1
countries with a recruiting site
as of 7 Sept 2026
7 Aug 2023
most recent study posted
among recruiting studies
Recruiting trials
RecruitingPhase 1NCT03017820
A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma
RecruitingNCT05978141
A Registry for People With T-cell Lymphoma
RecruitingNCT01137643
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Showing the 4 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
Search all Primary cutaneous anaplastic large cell lymphoma studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Primary cutaneous anaplastic large cell lymphoma study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Primary cutaneous anaplastic large cell lymphoma
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations, and the genes involved (TYK2, NPM1).
Treatments being studied
6 approved treatments and 49 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Approved: Mechlorethamine Hydrochloride (Mustargen)Approved: Denileukin Diftitox (Ontak)Approved: Vorinostat (Zolinza)Approved: Romidepsin (Chromadax)Approved: Methoxsalen (8-mop)Approved: Bexarotene (Bexarotene)
Phase 3Mogamulizumab (Poteligeo)
Phase 3Hypericin
Phase 3Brentuximab Vedotin (Adcetris)
Phase 2Remetinostat
Phase 2Dimethyl Fumarate (Dimethyl fumarate accord)
Phase 2Ggti-2418
Phase 2Zanolimumab (Humax-cd4)
Phase 2Lenalidomide (Lenalidomide accord)
+ 41 more in development
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).